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Abstract
A truncated form of annexin I, formed during Ca2-induced translocation to neutrophil specific granules and secretory
vesicles/plasma membranes, is generated through the action of an endogenous membrane protease. The cleavage of annexin I
is inhibited by the metalloprotease inhibitor 1,10-phenanthroline as well as by Triton X-100 and dithiothreitol, classifying the
protease as a membrane-bound, thiol-dependent metalloprotease. The cleavage site is located close to the N-terminal of
annexin I, leaving a truncated form of the molecule, des1ÿ8 annexin I, that contains the Ca2-binding sites, as well as a
number of phosphorylation sites of importance for the function of the protein. When assessing binding capacity to different
neutrophil organelles, full-length annexin I bound to azurophil granules, specific granules, and secretory vesicles/plasma
membranes, while des1ÿ8 annexin I only bound to specific granules and secretory vesicles/plasma membranes, but not to
azurophil granules (C. Sjo« lin, C. Dahlgren, Biochim. Biophys. Acta 1281 (1996) 227^234). This implies that there are
different mechanisms of binding to neutrophil organelles of full-length annexin I and the truncated form, and that cleavage
of annexin I might be of regulatory importance for the degranulation process. ß 1999 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Annexin I is a member of the annexin family of
calcium-dependent, phospholipid-binding proteins
[1^4]. Much structural and biochemical data on an-
nexin I (as well as on other members of the family)
have been published [5^9], yet our understanding of
the precise biological function(s) of this protein is
vague. The fact that annexin I is a fusogenic protein
[10^13] suggests that it may be part of the secretory
machinery present in many di¡erent cell types [2,14^
17]. The core of annexin I is made of four repeats of
a consensus sequence of 70 amino acids carrying the
biochemical properties of Ca2 dependency and
phospholipid binding. The N-terminal domain of an-
nexin I is essential for the biological function(s) of
the molecule. The membrane-binding and vesicle ag-
gregation characteristics of the protein are regulated
by phosphorylation of the N-terminal domain [18^
21] and the calcium sensitivity for membrane binding
is altered in N-terminal truncated forms of the mol-
ecule [21], possibly due to conformational changes of
the protein induced by such truncations.
0005-2736 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 3 6 ( 9 8 ) 0 0 2 1 2 - 0
* Corresponding author. Fax: +46-31-828898;
E-mail : charlotta.movitz@microbio.gu.se
BBAMEM 77517 31-12-98
Biochimica et Biophysica Acta 1416 (1999) 101^108
Annexin I present in human neutrophils [11,15,22]
binds without selectivity to all the di¡erent granule
membranes (azurophil granules, speci¢c granules as
well as secretory vesicles/plasma membranes). How-
ever, the neutrophils possess a protease that can
cleave the annexin I molecule during translocation
of the protein to the speci¢c granules and the secre-
tory vesicles/plasma membranes. The truncated form
of annexin I shows a selectivity with respect to bind-
ing that the full-length protein lacks [23]. The trun-
cated form binds Ca2-dependently to the speci¢c
granules and the secretory vesicles/plasma mem-
branes, but not to the azurophil granules. These
data support the idea that annexin I together with
its truncated derivative may have roles in the hier-
archical mobilization of the di¡erent granule popu-
lations present in neutrophils. Very little is known
concerning the mechanism responsible for cleavage
of annexin I during calcium-induced translocation.
In the present study we show that an N-terminal
truncated form of annexin I, des1ÿ8 annexin I, is
generated through the action of a membrane-bound
metalloprotease.
2. Materials and methods
2.1. Materials
Reagents used in this work were obtained from the
following sources: Percoll and Ficoll-Paque were
purchased from Pharmacia, Uppsala, Sweden. ATP,
5-bromo-4-chloro-3-indolyl phosphate, EGTA,
Hepes, NBT, PMSF, Triton X-100 and histidine
were products of Sigma Chemical Co., St. Louis,
MO. 3,4-Dichloro-isocoumarin, DFP, and 1,10-
phenanthroline were obtained from Aldrich, Stein-
hem, Germany. Yeast Nitrogen Base without amino
acids was obtained from Difco Laboratories, Detroit,
MI. Aprotinin, E-64, pepstatin, leupeptin and Pefa-
bloc were obtained from Boehringer Mannheim,
Mannheim, Germany. The PVDF membrane was a
product of Millipore, Bedford, MA. Goat anti-
mouse IgG was obtained from Jackson Immuno-
Research Laboratories, West Grove, PA. Monoclo-
nal mouse anti-annexin I was from Zymed Labora-
tories, San Francisco, CA.
2.2. Puri¢cation of recombinant human annexin I
Human annexin I cDNA (subcloned into plasmid
YEpDB60) was kindly provided by Dr. C. Creutz,
Department of Pharmacology, University of Virgin-
ia, Charlottesville, VA. Recombinant annexin I was
expressed in Saccharomyces cerevisiae, strain C2Y6,
as described [24]. The vector incorporates the pro-
moter region of the GAL10 gene and yeast cells
grown on galactose medium provide a high expres-
sion level of annexin I. The recombinant protein was
isolated from yeast extract by calcium-dependent lip-
id binding, using endogenous yeast membranes as the
lipid source [25].
Brie£y, a yeast culture was grown to a density of
1U108 cells/ml in synthetic minimal galactose me-
dium supplemented with histidine (2% galactose,
1.6 g/l yeast nitrogen base without amino acids,
11.1 g/l succinic acid, 0.5% (w/v) ammonium sulfate,
20 mg/l histidine, and V7 g/l NaOH, pH 7.3). Cells
were harvested by centrifugation and washed once in
bu¡er H (20 mM Hepes (pH 7.4), at 4‡C, 150 mM
KCl, 2 mM MgCl2, 2 Wg/ml aprotinin, 0.5 mM phen-
ylmethylsulfonyl£uoride (PMSF) and 1 mM Pefa-
bloc). The pellet was resuspended in bu¡er H and
lysed at 320‡C using an X-press [26]. The homoge-
nate was centrifuged at 14 400Ug (10 min, 4‡C), and
Ca2 (4 mM) was added to the supernatant which
was left on ice for 15 min, and centrifuged at
100 000Ug (30 min, 4‡C). The pellet was washed
twice in bu¡er H. The ¢nal pellet was resuspended
in bu¡er H with EGTA (5 mM), left on ice for 15
min and centrifuged at 200 000Ug (30 min, 4‡C).
Finally, the EGTA-containing bu¡er was exchanged
for relaxation (100 mM KCl, 3 mM NaCl, 3.5 mM
MgCl2, 10 mM Pipes, pH 7.4) bu¡er supplemented
with 1 mM Pefabloc using a PD-10 Sephadex G-25
M column (Pharmacia Biotech, Uppsala, Sweden).
2.3. Isolation of granulocytes
Human polymorphonuclear leukocytes (neutrophil
granulocytes) were isolated from bu¡y coats [27].
Brie£y, erythrocytes were sedimented in dextran
and leukocytes were collected from the supernatant
by centrifugation and puri¢ed from remaining eryth-
rocytes by hypotonic lysis. Mononuclear leukocytes
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were removed by centrifugation on Ficoll-Paque. The
puri¢ed granulocytes were washed twice in Krebs^
Ringer medium without Ca2 (120 mM NaCl,
4.9 mM KCl, 1.2 mM MgSO4, 1.7 mM KH2PO4,
8.3 mM Na2HPO4, 10 mM glucose, pH 7.3) and
resuspended in cold relaxation bu¡er supplemented
with 1 mM ATP(Na)2, 0.5 mM PMSF, and 1 mM
Pefabloc.
2.4. Disruption of cells and isolation of cytosol and
subcellular organelles
Neutrophil cytosol and subcellular organelles were
isolated according to the method described by Bor-
regaard et al. [28]. Neutrophils in relaxation bu¡er
were disrupted by nitrogen cavitation (2500 kPa,
5 min; Parr, Moline, IL), and EGTA (1.5 mM)
was added to the homogenate to avoid aggregation
of granules. The homogenate was centrifuged at
400Ug (15 min, 4‡C) and the post-nuclear superna-
tant was layered onto discontinuous Percoll gra-
dients. Percoll, EGTA (15 mM), relaxation bu¡er
(10U concentrated), and distilled water were mixed
to give solutions of densities 1.05 g/ml and 1.12 g/ml.
A portion of 14 ml of the light solution was under-
laid with 14 ml of the heavier solution and the post-
nuclear supernatant was layered on top of the gra-
dient. After centrifugation at 32 800Ug (35 min, 4‡C)
using a ¢xed-angle Beckman JA20 rotor, three bands
were visible and collected with a Pasteur pipette. The
bands characterized by marker protein analysis are
denoted K (azurophil granules, myeloperoxidase as
marker), L (speci¢c granules, vitamin B12 binding
protein as marker) and Q (secretory vesicles/plasma
membranes, alkaline phosphatase as marker) in or-
der of decreasing density [22,28]. The cytosol was
prepared from the post-nuclear supernatant without
addition of EGTA. The supernatant was centrifuged
for 60 min (100 000Ug, 4‡C) to remove the organ-
elles.
In order to remove proteins loosely associated with
membranes, the Q-fraction was ¢rst washed in relax-
ation bu¡er (centrifuged at 100 000Ug, 30 min, 4‡C),
then with the same bu¡er supplemented with 1 M
NaCl, and ¢nally in relaxation bu¡er once again
before use in translocation experiments with
recombinant annexin I. This procedure has been
shown to remove proteins loosely associated with
the plasma membrane and leaves integral membrane
proteins such as the b-cytochrome of NADPH-oxi-
dase [29].
2.5. Calcium-induced translocation of annexin I
Puri¢ed recombinant annexin I (1U108 yeast cell
equivalents) or neutrophil cytosol (1U108 cell equiv-
alents) in relaxation bu¡er (1 mM Pefabloc) was
mixed with secretory vesicles/plasma membranes
(3U108 cell equivalents) in relaxation bu¡er (con-
taining 1 mM Pefabloc) and either EGTA (1 mM)
or Ca2 (1 mM) was added. The mixtures were in-
cubated for 15 min at 37‡C and centrifuged at
65 000Ug for 15 min. The collected membranes
were washed once, resuspended in relaxation bu¡er
(1 mM Pefabloc, 2 mM EGTA; 300 Wl), incubated
for 15 min, and centrifuged at 22 000 psi (20 min,
4‡C) in an airfuge (Beckman Instruments, Fullerton,
CA). The supernatants, containing calcium-depend-
ent, phospholipid-binding proteins, were stored in
sample bu¡er (reduced) at 320‡C until analyzed.
2.6. Proteolytic cleavage of annexin I
Granules (5U106 cell equivalents) were mixed with
recombinant annexin I (1U107 yeast cell equivalents)
and Ca2 (2 mM) or EGTA (2 mM) was added. The
samples were incubated for 30 min at 37‡C in the
absence or presence of one of the protease inhibitors
or dithiothreitol and Triton X-100. The mixtures
were stored in sample bu¡er at 320‡C until analysis.
2.7. Amino acid sequencing of the N-terminally
truncated form of annexin I
Neutrophils were isolated from 20 bu¡y coats.
Cells in relaxation bu¡er were disrupted by nitrogen
cavitation. Cytosol and secretory vesicles/plasma
membranes were isolated and mixed in a ratio of
1:1. Ca2 (2 mM) was added to induce translocation
of annexin I to secretory vesicles/plasma membranes
(as described in Section 2.5). The ¢nal EGTA extract
was mixed with sample bu¡er, electrophoretically
separated, and transferred to a PVDF-membrane.
Proteins were visualized by staining with Coomassie
Brilliant blue. The truncated form of annexin I was
excised from the membrane and subjected to auto-
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mated Edman degradation and the amino acid se-
quence was scanned against the Swissprot databank
(P04083) for determination of the cleavage site.
2.8. SDS^PAGE and immunoblotting
Proteins from equal amount of cells were sepa-
rated by sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) in 10% polyacrylamide
gels [30] and either transferred electrophoretically to
PVDF membranes [31] or silver-stained. The PVDF
membranes were incubated in blocking bu¡er (1%
BSA, 1% skimmed milk, 0.05% Tween-20 in PBS)
for 1 h in room temperature and then for at least
1 h with monoclonal mouse anti-annexin I antibodies
(1:5000 dilution). The membranes were ¢nally incu-
bated with alkaline phosphatase-conjugated goat
anti-mouse IgG (1:2000 dilution). The blots were
developed with bromochloroindolyl phosphate
(BCIP; 0.15 mg/ml) and Nitro Blue tetrazolium
(NBT; 0.3 mg/ml) in 0.1 M NaHCO3, 1 mM MgCl2,
pH 9.8.
3. Results
3.1. Translocation of cytosolic proteins to neutrophil
organelles
Previous work has shown that annexin I (as well as
several other members of the annexin family) is able
to bind Ca2-dependently to all the di¡erent types of
neutrophil organelles which can be isolated on Per-
coll gradients (i.e., azurophil granules, speci¢c gran-
ules, and secretory vesicles/plasma membranes)
[22,23]. In contrast to the full-length annexin I mol-
ecule (40 kDa), a truncated form of the protein (39
kDa) binds only to the speci¢c granules and secre-
tory vesicles/plasma membranes but not to the azur-
ophil granules [23] (Fig. 1). The fact that only the
full-length annexin I was present in the cytosol, in-
dicates that the molecule is cleaved during the trans-
location process. Our earlier results imply that the
annexin I-cleaving protease is present in the speci¢c
granules and the secretory vesicles/plasma mem-
branes but not in the azurophil granules. From these
experiments we could not determine whether the pro-
tease is cytosolic and co-translocates with annexin I
to the organelles or exerts its action primarily on the
membrane-bound annexin I molecule.
3.2. Translocation of recombinant annexin I
To determine the localization of the protease re-
sponsible for cleavage of the annexin I molecule we
depleted the translocation system from other cyto-
solic proteins through the use of recombinant human
annexin I.
The recombinant annexin I was cleaved Ca2-de-
pendently (Fig. 2) also in the absence of cytosolic
proteins and both full-length annexin I and the trun-
cated form of the molecule were also bound Ca2-
dependently (no cleavage or binding at concentra-
tions lower than 0.1 mM) to the neutrophil speci¢c
granules and secretory vesicles/plasma membranes
(shown for the secretory vesicles/plasma membranes
in Fig. 3). Loosely associated membrane proteins
were removed by high salt washing prior to the
translocation experiments. However, the ability to
cleave annexin I was retained also in the washed
membranes (shown for the secretory vesicles/plasma
membranes in Fig. 4). Taken together, these results
show that the protease responsible for truncation of
annexin I during translocation to the speci¢c gran-
ules and the secretory vesicles/plasma membranes is
not cytosolic, but is integrated in the membrane of
these neutrophil organelles.
Fig. 1. Translocation of annexin I in neutrophil cytosol to se-
cretory vesicles/plasma membranes. Isolated secretory vesicles/
plasma membranes were mixed with cytosol in the presence of
Ca2 (2 mM) or EGTA (2 mM). The membranes were collected
and washed. Annexin I was released from the membranes by
extraction in an EGTA-containing bu¡er. The organelles were
removed and the supernatants were electrophoresed under re-
ducing conditions, electroblotted onto PVDF membranes, and
detected with mouse anti-annexin I antibodies. The cytosol con-
tained only full-length annexin I (40 kDa, right). The 40 kDa
annexin I and a 39 kDa truncated form were detected following
translocation in the presence of Ca2 (left), but not in the pres-
ence of EGTA (middle).
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3.3. Determination of the cleavage site on annexin I
The truncated form of annexin I was excised from
a PVDF membrane after separation by SDS^PAGE
and subsequent transfer. The protein was subjected
to automated Edman degradation to determine the
N-terminal sequence of the protein. We found that
the N-terminus was composed of the amino acids K^
Q^A^W^F^I, a sequence that only matched the hu-
man annexin I sequence [32], starting at amino acid
number nine from the N-terminus of the full-length
protein (Table 1). Subsequently, the 39 kDa trun-
cated annexin I molecule lacks the eight ¢rst amino
acids (hereafter called des1ÿ8 annexin I) of the full-
length protein, and the protease thus cleaves the pro-
tein between the amino acids leucine and lysine in
position 8 and 9, respectively, of the annexin I mol-
ecule.
3.4. Classi¢cation of the annexin I-cleaving protease
To classify the protease, inhibitor studies were per-
formed and the results are shown in Table 2. We
found that the serine protease inhibitors phenyl-
methylsulfonyl£uoride, Pefabloc, diisopropyl£uoro-
phosphate, and leupeptin had no e¡ect on the cleav-
age of annexin I, and this was true also for the
aspartic proteinase inhibitor pepstatin and the cys-
teine proteinase inhibitor E-64. The cleavage of an-
nexin I was, however, totally inhibited by 1,10-phen-
anthroline, indicating that the enzyme is a
metalloprotease, of which the very great majority
are zinc-containing enzymes [33].
The importance of thiol groups were studied by
the inclusion of dithiothreitol (5 mM) to the reaction
mixture which completely inhibited the cleavage of
the annexin I molecule, suggesting that the metallo-
protease requires intact disul¢de bonds for proteo-
lytic activity. A lower concentration of dithiothreitol
partially inhibited the protease. The cleavage of an-
nexin I was also partly inhibited by Triton X-100,
Fig. 4. Translocation of recombinant annexin I to secretory
vesicles/plasma membranes depleted of peripheral membrane
proteins. These secretory vesicles/plasma membranes were mixed
with recombinant annexin I in the presence of Ca2 (1 mM) or
EGTA (1 mM). The secretory vesicles/plasma membranes were
collected and washed. The annexin I molecules were released
from the organelles by extraction in an EGTA-containing buf-
fer. The organelles were removed, the supernatants were electro-
phoresed under reducing conditions and electroblotted onto a
PVDF membrane, and detected with mouse anti-annexin I
monoclonal antibodies. The full-length recombinant annexin I
(40 kDa, right), as well as a 39 kDa truncated form was de-
tected following calcium-induced translocation (left). In the
presence of EGTA, translocation was inhibited (middle).
Fig. 3. Translocation of recombinant annexin I to secretory
vesicles/plasma membranes. Recombinant annexin I (anx I) was
mixed with isolated secretory vesicles/plasma membranes in the
presence of Ca2 (1 mM) or EGTA (1 mM). The membranes
were collected and washed. Annexin I was released from the
membranes by extraction in an EGTA-containing bu¡er. The
organelles were removed, the supernatants were electrophoresed
under reducing conditions and electroblotted onto PVDF mem-
branes, and detected with mouse anti-annexin I monoclonal
antibodies. The full-length recombinant annexin I (40 kDa,
right), as well as a 39 kDa truncated form was detected follow-
ing calcium-induced translocation (left). In the presence of
EGTA, translocation was inhibited (middle).
Fig. 2. Cleavage of recombinant annexin I by secretory vesicles/
plasma membranes. Recombinant annexin I (anx I) was incu-
bated with secretory vesicles/plasma membranes in the presence
of Ca2 (2 mM) or EGTA (2 mM) for 30 min at 37‡C. With-
out further processing, the samples were electrophoresed under
reducing conditions and electroblotted onto PVDF membranes
and detected with mouse anti-annexin I antibodies. The full-
length recombinant annexin I (40 kDa, right) was cleaved
Ca2-dependently to generate a 39 kDa truncated form (left).
The cleavage of annexin I was inhibited by EGTA (middle).
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suggesting that the protease works more e⁄ciently in
an intact membrane.
4. Discussion
The truncated form of annexin I that is formed
during Ca2-regulated in vitro translocation and
binding of the protein to neutrophil secretory
vesicles/plasma membranes is generated through the
action of an endogenous membrane protease. Such
protease activities have been described also in other
cells [34], but the responsible protease(s) has so far
not been identi¢ed through isolation. There are many
similarities between the neutrophil annexin I-cleaving
protease and that found in other cells [34]: (i) it is
membrane bound; (ii) annexin I but not other mem-
bers of the annexin family of Ca2-regulated mem-
brane binding proteins are cleaved by the proteases,
indicating that these membrane proteases recognize
speci¢c sites within the annexin I molecule; (iii) the
activity is inhibited by Triton X-100 and dithiothrei-
tol. Based on the inhibitory activity of 1,10-phenan-
throline and dithiothreitol, we classify the neutrophil
annexin I cleaving protease as a membrane-bound,
thiol-dependent metalloprotease. Membrane-bound
metalloproteases and metallopeptidases have been
described in other cell types [35^37], and it is inter-
esting to notice that it has been suggested that their
function may involve regulation of intracellular sig-
naling achieved through cleavage of cytoplasmic
messenger molecules [35].
The annexin I molecule is cleaved also during
Ca2-regulated translocation to the speci¢c granules
(but not to the azurophil granules). Although we
have not characterized this cleavage in detail our
results strongly suggest that the same protease is
present in the speci¢c granules.
Cleavage of annexin I has been reported to occur
at many di¡erent sites, more or less close to the N-
terminus of the molecule (e.g., cleaved at lysine9, at
tryptophan12, at lysine26 and lysine29) [20,21,38,39].
We found that cleavage of annexin I by the neutro-
phil annexin I-cleaving metalloprotease, occurs close
to the N-terminal of the molecule, leaving a trun-
cated form of the molecule, des1ÿ8 annexin I, that
contains the Ca2-binding consensus sequence, as
well as a number of phosphorylation sites (i.e., ty-
rosine21, threonine24, serine27 and serine28) of impor-
tance for protein function. This cleavage site is
unique for the neutrophil annexin I cleaving pro-
teinase.
As mentioned, members of the annexin family pos-
sess a structurally homologous core region. This part
of the annexins is responsible for Ca2- and phos-
Table 2
E¡ect of di¡erent inhibitors on the cleavage of annexin I medi-
ated by a neutrophil protease present in the secretory vesicles/
plasma membranes
Inhibitor used Concentration E¡ect
DTT 1 mM +a
DTT 5 mM ++b
Triton X-100 1.0% +
Metalloprotease inhibitor
1,10-Phenanthroline 1 mM ++
Serine proteinase inhibitors
3,4-DCl 1 mM 3c
Pefabloc 1 mM 3
PMSF 1 mM 3
DFP 0.2 Wg/ml 3
Leupeptin 10 WM 3
Aspartic proteinase inhibitors
Pepstatin 10 WM 3
Cysteine proteinase inhibitors
E-64 4 Wg/ml 3
aCleavage was partially inhibited.
bCleavage was completely inhibited.
cNo inhibition of cleavage.
Table 1
Amino acid sequence of the truncated annexin I molecule, re-
covered after translocation of full-length annexin I to secretory
vesicles/plasma membranesa
aThe protein was transferred to a PVDF-membrane from an
SDS^PAGE gel. The truncated form of annexin I was excised
from the membrane and subjected to automated Edman degra-
dation. The sequence of human full-length annexin I was com-
pared with the N-terminal sequence of the truncated annexin I
molecule.
BBAMEM 77517 31-12-98
C. Movitz et al. / Biochimica et Biophysica Acta 1416 (1999) 101^108106
pholipid-binding and interaction with cytoskeletal
components. In contrast, the N-terminal regions are
structurally diverse and confer the speci¢c functions
of the di¡erent members of the annexin family. With
respect to the function of annexin I, many studies
have shown its capacity to promote granule aggrega-
tion and membrane fusion, indicating that the mole-
cule may constitute part of a secretory apparatus
[10^13]. Modulation of the N-terminus of the mole-
cule has thus been suggested to be of importance as a
basis for regulation of secretory and fusogenic events
[7,11,19,20,38,39]. In contrast to the full-length an-
nexin I, des1ÿ8 annexin I binds only to speci¢c gran-
ules and secretory vesicles/plasma membranes and
not to azurophil granules [23], implying di¡erent
mechanisms for binding to neutrophil organelles of
full-length annexin I and des1ÿ8 annexin I. The in-
ability of des1ÿ8 annexin I to bind azurophil granules
is probably not an e¡ect of an altered calcium sensi-
tivity (which has been described for truncated annex-
in I molecules in other biological systems) as the
truncated forms of annexin I usually require less cal-
cium for membrane binding or vesicle aggregation
[14,20,21]. All in all, our data provide support for
the idea that the presence of both full-length annexin
I and des1ÿ8 annexin I in neutrophils may be of
importance in di¡erential exocytosis. It is also inter-
esting to note that the selectivity in annexin I binding
has been described in other cells, and it has been
suggested that the protein and its derivatives are in-
volved in endocytic processing [38]. This suggestion
originates from the observation that translocation of
annexin I to early endosomes was found to critically
depend on the presence of an intact N-terminal do-
main of the molecule whereas association with late
endosomes requires an N-terminal truncation of the
molecule.
The cleavage of annexin I may be of regulatory
importance for the neutrophil degranulation process,
since the truncated form of annexin I shows di¡er-
ential binding capacity to the neutrophil granules. It
may also be of importance for the processing and
maturation of endocytic vesicles formed during ma-
turation of the cells in the bone marrow (i.e., the
secretory vesicles formed through an endocytic proc-
ess during the later stages of myelopoiesis [40]) or
during uptake and killing of foreign microorganisms
(phagosome formation and phagolysosomal matura-
tion following endocytic uptake of particles) [41].
Furthermore, annexin I-binding to neutrophil organ-
elles may be a good model to disclose the molecular
background to the phenomenon of cytosolic proteins
which bind selectively to di¡erent subcellular organ-
elles.
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